ArticleJMIR formative research2026
Dual-Source Retrieval-Augmented Generation Chatbot for Women's Health (HerCare): Design and Multimethod Evaluation Study.
Article in JMIR formative research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Background: Conversational agents for women's health often fail to meet user needs, offering either clinically sterile advice or unreliable peer anecdotes. This limitation creates a tension between the need for factual safety and emotional resonance in sensitive health contexts. Objective: We aimed to address this gap by developing and conducting a formative evaluation of HerCare, a conversational agent built on a novel dual-source retrieval-augmented generation architecture. The system integrates expert medical knowledge with peer narratives and makes the provenance of each response visible to users, enabling trust calibration through transparent source attribution. Methods: We conducted a remote, web-based single-session field study (December 2024 to January 2025; North Dakota State University Institutional Review Board Protocol #IRB0005368) with 243 completers (from 335 eligible, consenting visitors) recruited via social media (Facebook [Meta], Reddit, and Instagram [Meta]) and university mailing lists. Eligible participants self-identified as women aged 18-45 years with English proficiency and internet access. We used a quantitative multimethod evaluation, combining standardized self-report metrics-the Chatbot Usability Questionnaire and net promoter score (NPS)-with computational linguistic analyses (VADER [Valence Aware Dictionary and Sentiment Reasoner] sentiment analysis and NRC [National Research Council] Emotion Lexicon) of 1191 conversational turns. Results: Among the 243 participants who completed the protocol, reported usability was high (Chatbot Usability Questionnaire median 78.1, IQR 65.2-87.5; mean 75.67, SD 15.50) and advocacy was strong (NPS 60.0; 171/243, 70.4% promoters, 25/243, 10.3% detractors), though this NPS reflects completers only. Postinteraction ratings were high (all facets median 4-5 on a 5-point scale; helpfulness, ease of use, and clarity median 5, IQR 4-5). Computational analysis revealed a consistent polarity shift from neutral to negative user queries (compound -0.18 to +0.15) to strongly positive agent responses (compound +0.55 to +0.83), with a recurring validate-then-redirect empathy pattern in which the agent acknowledges user distress before pivoting to constructive guidance. Conclusions: Among completers, the dual-source architecture was associated with high perceived empathy and trust, suggesting it can combine clinical accuracy with emotional support. These formative findings indicate the feasibility of weaving clinical sources with lived experiences toward safer, more resonant health AI and surface a candidate design pattern for future empathy-attuned systems that warrants controlled evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.